Biological Effects of 224Ra: Benefit and Risk of Therapeutic Application Proceedings of the Second Symposium at Neuherberg/München, September 20–21, 1976

Front Matter....Pages i-viii
Preface....Pages 1-4
On the scientific work of Fritz Schales....Pages 5-6
Opening Address: W. Gössner....Pages 7-10
Zur Klinik der ankylosierenden Spondylitis (Morbus Bechterew)....Pages 11-18
Pathology and radiology of ankylosing spondylitis....Pages 19-20
Indication for 224 Ra-therapy in ankylosing spondylitis (Morbus Struempell-Bechterew-Marie)....Pages 21-29
Problems and results of a new follow-up study - 224 Ra in adult ankylosing spondylitis patients....Pages 30-36
Addendum to the previous paper: risk to bone from present 224 Ra therapy....Pages 37-43
Quality control in the production process and purity of 224 Ra for injection....Pages 44-49
Therapeutical results in a follow-up study on 224 Ra-therapy of ankylosing spondylitis....Pages 50-59
X-Ray therapy in the treatment of ankylosing spondylitis....Pages 60-69
Radiosynoviorthesis: local treatment of rheumatoid arthritis....Pages 71-78
Comparison of the efficacy of 224 Ra and other radio-isotopes in the treatment of rheumatoid arthritis....Pages 79-86
Experimental data on the injection of 224 Ra into the kneejoint of rats and rabbits....Pages 87-94
Intravenous injection of 224 Ra in morbus Paget....Pages 95-101
Clinical experiences concerning late effects and risks of 224 Ra....Pages 102-108
Osteogenic sarcomas in mice after 224 Ra or 226 Ra administrations....Pages 109-119
Biological effects of 224 Ra and 226 Ra and their relative radiotoxicity in mice....Pages 120-134
The Dependence of late effects in mice on the temporal distribution of skeletal α-doses from 224 Ra and 227 Ra....Pages 135-148
Histopathology of early effects of 224 Ra on bone tissue....Pages 149-157
Expression of type C RNA virus particles in 224 Ra-induced osteosarcomas....Pages 158-167
Bone sarcoma to man from 224 Ra, 226 Ra, and 239 Pu....Pages 168-181
Problems in radiological protection involving α-emitters in bone....Pages 182-200
A model for the induction of bone cancer by 224 Ra....Pages 201-209
Methodological aspect of epidemiological inquiries in clinical radiobiology....Pages 210-211
Notre expérience du 224 Ra dans le traitement de la spondylarthrite ankylosante....Pages 212-214
Erratum to: Osteogenic sarcomas in mice after 224 Ra or 226 Ra administrations....Pages 237-237
Erratum to: Problems in radiological protection involving α-emitters in bone....Pages 237-237
Back Matter....Pages 215-236